Partner with Americord for

Birth Tissue & 
Blood Recovery

Americord offers placenta, umbilical cord, and cord blood donations for hospitals and birthing centers, supporting medical research and innovative treatments.

Contact Us Today
Placental tissue americord

Clinical Applications for Placental Tissue & Amniotic Membrane

Placental tissue and amniotic membrane donations are paving the way for innovative treatments and therapies in modern medicine. Your participation in Americord’s donation program can significantly enhance clinical research and improve patient care.

    • Burns: Used for partial-thickness burns to promote healing and reduce pain.
    • Venous Stasis Ulcers: Applied to chronic venous stasis ulcers to accelerate healing.
    • Pressure Ulcers: Used to treat bedsores that do not respond well to conventional treatments.

    • Tendon and Ligament Injuries: Applied to injuries like tendinitis and ligament sprains to enhance recovery and reduce inflammation.
    • Plantar Fasciitis: Injected or applied to reduce pain and inflammation associated with plantar fasciitis.

    • Persistent Epithelial Defects: Used in patients with non-healing corneal epithelial defects that do not respond to standard treatments.
    • Severe Dry Eye Syndrome: Applied in severe cases of dry eye to promote healing of the ocular surface and reduce symptoms.

    • Plastic and Cosmetic Surgery: Used as a biological dressing in various reconstructive procedures to improve healing and reduce scarring.
    • Breast Reconstruction: Applied in breast reconstruction surgeries to support tissue regeneration and reduce adhesions.

    • Vaginal Reconstruction: Used in surgical procedures for vaginal reconstruction to support tissue healing and reduce scarring.
    • Asherman's Syndrome: Applied to the uterine lining to reduce intrauterine adhesions and improve endometrial health.

    • Bladder Augmentation: Used in procedures to augment the bladder, aiding in tissue regeneration and reducing complications.

Clinical Applications for Umbilical Cord Tissue

Umbilical cord tissue donations are driving breakthroughs in regenerative medicine, offering new hope for treating various conditions. Your participation in Americord’s donation program can play a crucial role in advancing clinical research and enhancing patient outcomes.

• Joint Injuries, Tendon and Ligament Injuries, Arthritis: These applications are largely in the research phase, with some being used off-label by practitioners based on preliminary evidence and clinical experience.

• Chronic Ulcers, Surgical Wounds: These uses are typically in the research phase or used off-label. Some wound care products derived from umbilical cord tissue may be FDA-cleared as wound dressings, but their specific application to chronic ulcers and surgical wounds as described is not FDA-approved.

• Nerve Injuries, Neurodegenerative Diseases: These are primarily in the research phase with ongoing clinical trials exploring their efficacy and safety.

• Heart Repair, Peripheral Artery Disease: These applications are in the experimental phase with active research and clinical trials assessing their potential benefits.

• Corneal Defects, Dry Eye Syndrome: These uses are mostly in the research phase or used off-label based on promising results from preliminary studies and clinical trials.

• Skin Grafts, Burn Treatment: Some applications are in the research phase, while others might be used off-label. Specific products derived from umbilical cord tissue may be used in wound care, but not necessarily FDA-approved for these detailed applications.

• Pelvic Floor Disorders, Endometrial Regeneration: These applications are largely in the research phase, with ongoing studies exploring their potential benefits.

FDA-Approved Cord Blood Treatments

There are now over 80 medical conditions that can be treated with the hematopoietic stem cells (HSCs) collected from cord blood. For some diseases these treatments are the only therapy, and in other diseases they are only employed when front-line therapies have failed or the disease is very aggressive. In the United States, most health insurance providers will pay for a stem cell transplant if it is a "standard therapy" for the patient's diagnosis.

Leukemias: a cancers of the blood immune system, where the cells are called leukocytes or white cells.
     • Acute Biphenotypic Leukemia
     • Acute Lymphoblastic Leukemia (ALL)
     • Acute Myelogenous Leukemia (AML)
     • Acute Undifferentiated Leukemia
     • Chronic Lymphocytic Leukemia (CLL)
     • Chronic Myelogenous Leukemia (CML)
     • Juvenile Chronic Myelogenous Leukemia (JCML)
     • Juvenile Myelomonocytic Leukemia (JMML)
Myelodysplastic Syndromes: also called pre-leukemia.
     • Refractory Anemia
     • Refractory Anemia with Ringed Sideroblasts
     • Refractory Anemia with Excess Blasts
     • Refractory Anemia with Excess Blasts in Transformation
     • Chronic Myelomonocytic Leukemia (CMML)
Lymphomas: a cancer of the blood immune system, where the cells are called leukocytes or white cells.
     • Hodgkin’s Lymphoma
     • Non-Hodgkin’s Lymphoma (Burkitt’s Lymphoma)
Solid Tumors: not originating in the blood or immune system.
     • Neuroblastoma
     • Retinoblastoma
     • Medulloblastoma

Anemias: deficiencies or malformations of red cells.
     • Aplastic Anemia
     • Congenital Dyserythropoietic Anemia
     • Fanconi Anemia
     • Paroxysmal Nocturnal Hemoglobinuria (PNH)
Inherited Red Cell (Erythrocyte) Abnormalities: red cells contain hemoglobin and carry oxygen to the body.
     • Beta Thalassemia Major (also known as Cooley’s Anemia)
     • Diamond-Blackfan Anemia
     • Pure Red Cell Aplasia
     • Refractory Anemia with Excess Blasts in Transformation
     • Sickle Cell Disease
Inherited Platelet Anomalies: platelets are blood cells needed for clotting.
     • Amegakaryocytosis / Congenital Thrombocytopenia
     • Glanzmann Thrombasthenia
Inherited Immune System Disorders | Severe Combined Immunodeficiency
     • SCID with Adenosine Deaminase Deficiency(ADA-SCID)
     • SCID which is X-linked
     • SCID with absence of T & B Cells
     • SCID with absence of T Cells, Normal B Cells
     • Omenn Syndrome
Inherited Immune System Disorders | Neutropenias
     • Infantile Genetic Agranulocytosis (Kostmann Syndrome)
     • Myelokathexis
Inherited Immune System Disorders | Other
     • Ataxia-Telangiectasia
     • Bare Lymphocyte Syndrome
     • Common Variable Immunodeficiency
     • DiGeorge Syndrome
     • Leukocyte Adhesion Deficiency
     • Lymphoproliferative Disorders
     • Lymphoproliferative Disorder, X-linked (also known as Epstein-Barr Virus Susceptibility)
     • Wiskott-Aldrich Syndrome
Myeloproliferative Disorders
     • Acute Myelofibrosis
     • Agnogenic Myeloid Metaplasia (Myelofibrosis)
     • Polycythemia Vera
     • Essential Thrombocythemia
Phagocyte Disorders
     • Chediak-Higashi Syndrome
     • Chronic Granulomatous Disease
     • Neutrophil Actin Deficiency
     • Reticular Dysgenesis
Cancers in the Bone Marrow
    • Multiple Myeloma
    • Primary Plasma Cell Leukemia (PCL)
    • Secondary Plasma Cell Leukemia
    • Waldenstrom’s Macroglobulinemia

Inherited Disorders: immune system and other organs.
    • Cartilage-Hair Hypoplasia
    • Gunther’s Disease (Erythropoietic Porphyria)
    • Hermansky-Pudlak Syndrome
    • Pearson’s Syndrome
    • Shwachman-Diamond Syndrome
    • Systemic Mastocytosis

Mucopolysaccharidosis (MPS) Storage Diseases
    • Hunter Syndrome (MPS-II)
    • Hurler Syndrome (MPS-IH)
    • Maroteaux-Lamy Syndrome (MPS-VI)
    • Morquio Syndrome (MPS-IV)
    • Sanfilippo Syndrome (MPS-III)
    • Scheie Syndrome (MPS-IS)
Sly Syndrome, Beta-Glucuronidase Deficiency (MPS-VII)
    • Mucolipidosis II (I-cell Disease)
Leukodystrophy Disorders
    • Adrenoleukodystrophy (ALD) / Adrenomyeloneuropathy (AMN)
    • Krabbe Disease (Globoid Cell Leukodystrophy)
    • Metachromatic Leukodystrophy
    • Pelizaeus-Merzbacher Disease
Lysomal Storage Disorders
    • Niemann-Pick Disease
    • Sandhoff Disease
    • Wolman Disease
Inherited Disorders-Other
    • Lesch-Nyhan Syndrome
    • Osteopetrosis

Why Should You Partner with Americord for Birth Tissue & Blood Donations?

At Americord, we believe in transforming the birth of a child into an opportunity for medical innovation and community enrichment. By participating in our donation program, hospitals and clinics can significantly impact patient care and medical research. Here’s why your institution should partner with us:

Americord donation program cost reduction

Cost Reduction

By reducing medical waste disposal costs, our program offers a practical solution to managing healthcare expenses.

Doctor carefully examining a young child while holding a teddy bear.

Reputation Enhancement

Position your hospital as a leader in innovative medical practices and exemplary patient care.

Hospital admins discussing the financial benefits of americords placenta donation program

Financial Support

Receive financial backing for your labor and delivery department, helping to enhance the resources available for maternal and neonatal care.

A happy family sitting together on a couch.

Community Contribution

Align with your hospital’s mission by contributing to the community and supporting life-saving medical advancements.

Hospital stakeholders discussing americord placenta donation prorgram

Stakeholder Engagement

Access detailed case studies and statistics on the use of donated tissues for internal and external stakeholders, showcasing the tangible benefits of your involvement.

Doctor talking with expecting mother about donating her placenta

Interested in Offering Placenta, Umbilical Cord and/or Cord Blood Donations for Your Patients?

Please provide a brief message about your clinic or hospital and specify if you're interested in our donation services and/or private biobanking services with Americord.

* required

Cord Blood Stem Cells Successfully Treat 5-Year Old with Autism

When Amanda and Shawn Fohs’ daughter, Olivia, was born in 2013, the couple decided to bank their daughter’s cord blood stem cells. Considering today’s scientific advancements and the potential for future uses, storing their daughter’s stem cells felt like a “no brainer.”

Cord blood stem cells are FDA-approved to treat more than 80 conditions, including childhood leukemia and sickle cell disease and are being studied in 100s of other clinical trials – including autism. The Fohs never imagined that these stem cells would be the key to reducing the severity of Olivia’s autism.

In January 2019 with a single, 15 minute procedure, Olivia’s cord blood stem cells helped reduce her autism severity from ASD level 2 (mild to moderate) to level 1.

Little girl embraces her favorite cartoon character in a warm hug.

Cord Blood Stem Cells Successfully Treat 10-Year Old with Sickle Cell Disease

Meet Eli (10) and Gus (3), brothers who have an inseparable bond—a bond forged by blood in more ways than one. Eli was born in 2010 with Sickle Cell Disease. Their parents banked Gus's cord blood for free through the Americord Cares program. And in 2020, Eli's Sickle Cell Disease was successfully treated with his brother's banked stem cells. Since the transplant, Eli’s mom shares that her son has been thriving and the doctors couldn’t be happier with his progress.

Two siblings smiling and sitting on a bench outdoors.